50% Dextrose Injection Shortage
Last Updated: May 31, 2023
Status: Current
Products Affected - Description
-
- 50% Dextrose intravenous injection, Amphastar, 50 mL Luer-Jet syringe, 10 count, NDC 76329-3302-01
- 50% Dextrose intravenous injection, Pfizer, 50 mL LifeShield syringe, 10 count, NDC 00409-4902-34
- 50% Dextrose intravenous injection, Pfizer, 50 mL Ansyr II Luer Lock syringe, 10 count, NDC 00409-7517-16
- 50% Dextrose intravenous injection, Pfizer, 50 mL vial, 25 count, NDC 00409-6648-02
Reason for the Shortage
-
- Amphastar has 50% dextrose on shortage due to increased demand.
- Pfizer has 50% dextrose on shortage due to increased demand.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Amphastar has 50% dextrose 50 mL syringes on allocation.
- Pfizer has 50% dextrose 50 mL Ansyr II syringes are on back order and the company estimates a release date of June 2023. The 50 mL LifeShield syringes are on back order and the company estimates a release date of June 2023. The 50 mL vials are on back order and the company estimates a release date of October 2023.
Updated
Updated May 31, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 12, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.